Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Sunitinib and Sorafenib in Advanced Renal Cell Carcinoma
NCT01481870Phase 3Unknown
- Sponsor
- Yamagata University
- Start
- Jan 2010
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sunitinib, sorafenib in metastatic renal cell carcinoma (mRCC), sponsored by Yamagata University. Status: unknown.
02
Drugs
sunitinibsorafenib
03
Conditions
metastatic renal cell carcinoma (mRCC)
Beyond the preview
Go deeper on NCT01481870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01481870.